Global Endoscopic Submucosal Dissection Market Report and Forecast 2024-2032

Endoscopic Submucosal Dissection Market Outlook

The endoscopic submucosal dissection market size was valued at USD 324.7 million in 2023, driven by the rising incidence of gastrointestinal cancer cases across the globe. The market is expected to grow at a CAGR of 7.0% during the forecast period of 2024-2032, with the values likely to rise from USD 347.3 million in 2024 to USD 594.5 million by 2032.

Endoscopic Submucosal Dissection: Introduction

Endoscopic submucosal dissection is a minimally invasive procedure conducted to examine and remove precancerous and cancerous areas in the GI (gastrointestinal) tract. It can be used to treat submucosal tumours and lesions. It is done through a tube-like flexible endoscope, which is either through the mouth or the anus. The endoscope is further guided to the irregular growth region to allow tumour marking.

Endoscopic submucosal dissection may be used to treat Barrett’s esophagus (it can cause precancerous lesions), esophagus cancer, colorectal cancer, stomach cancer, and small intestine cancer. 

Endoscopic Submucosal Dissection Market Analysis

The benefits of endoscopic submucosal dissection outweigh the traditional open surgery by offering a lower risk of complications, faster recovery, and less pain. Therefore, patients and healthcare professionals have shown a strong inclination towards adopting the minimally invasive procedure, resulting in escalated endoscopic submucosal dissection market demand.

To make the prevailing methods more accurate, less time consuming and affordable, technically advanced devices have emerged in the market. Hybrid knives can be considered as one such example. When compared to conventional IT knives, the ClearCut™ hybrid type knife improved the surgical efficacy by facilitating the procedure without any additional device attachment.

The endoscopic submucosal dissection market growth is driven by incessant product launches by established healthcare companies. In April 2023, Olympus launched an entire GI portfolio called EndoClot, which supports hemostasis and endoscopic submucosal dissection or resection lifting. It includes EndoClot adhesive, the EndoClot polysaccharide hemostatic spray and the EndoClot submucosal injection solution.

Penlon Limited also introduced an endoscopic accessories division in the United Kingdom in July 2023. This range of single use accessories offers synchronous bi-directional 360° rotation and accurate positioning, facilitating lower scope of errors in the surgery. With the launch of ClutchCutter and FushKnife, FUJIFILM India, the leading diagnostic and information system service provider announced their expansion in endoscopic solutions portfolio.

Endoscopic Submucosal Dissection Market Segmentation

Market Breakup by Type

• Grasp

• Clips

• Gastroscopes

• Colonoscopes

Market Breakup by Indications

• Cancer

• Stomach

• Colon

Market Breakup by End User

• Hospitals

• Ambulatory Surgical Centres

• Speciality Clinics

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Endoscopic Submucosal Dissection Market Overview

Colorectal cancer is the third most common category of cancer expected to affect around 153,020  individuals in the United States. Hence, the region is anticipated to lead the endoscopic submucosal dissection market share in the forecast period. With the rising incidence of cancer cases, the government has been working on spreading relevant preventive measures through awareness campaigns. The National Colorectal Cancer Awareness Month set up in February 2023 predominantly focused on early detection through underlying symptoms. The considerable market size can be associated with the presence of key healthcare companies in the area.

While the market has been dominated by North America in the historic period, Asia Pacific is set to experience impressive growth in the future. Along with advanced product launches, government initiatives and foreign investments in the region, there has been significant focus on educating and training the healthcare professionals to use the high-tech medical devices. The Department of Digestive Endoscopy at the Tokyo Women’s Medical University Hospital places prime emphasis on upskilling the staff for safe and efficient endoscopic submucosal dissection procedures. Such measures indicate that the endoscopic submucosal dissection market value will further expand.

Endoscopic Submucosal Dissection Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Olympus Corporation

• Boston Scientific Corporation

• FUJIFILM Holdings Corporation  

• T Sumitomo Bakelite Co., Ltd.

• Creo Medical

• Medtronic plc

• HOYA Corporation

• Ovesco Endoscope AG

• ConMed Corporation 

• A Steris PLC

Key Highlights of the Report